Clinical Trial: A Phase 1 Study to Evaluate the C-QTc Interval of QLC5508, Compare the Pharmacokinetics of Two Different Formulations, and Assess Drug-Drug Interaction Potential in Participants with Advanced Solid Tumors (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase 1 Study to Evaluate the C-QTc Interval of QLC5508, Compare the Pharmacokinetics of Two Different Formulations, and Assess Drug-Drug Interaction Potential in Participants with Advanced Solid Tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135746

Registration Time: 2026/11/02

Type: Interventional study

Primary Sponsor: Jilin Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=326093

Published by HT Digital Content Services with permission from Health Daily Digest....